Victory Capital Management Inc. Acquires 5,518 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Victory Capital Management Inc. lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 0.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 667,057 shares of the company's stock after acquiring an additional 5,518 shares during the period. Victory Capital Management Inc. owned 0.15% of GE HealthCare Technologies worth $52,151,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. LGT Financial Advisors LLC grew its holdings in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock valued at $25,000 after buying an additional 251 shares during the last quarter. Ashton Thomas Securities LLC acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at approximately $26,000. Capital Performance Advisors LLP acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at approximately $26,000. Darwin Wealth Management LLC acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at approximately $31,000. Finally, Continuum Advisory LLC grew its holdings in GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after buying an additional 168 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Price Performance

GEHC traded up $1.17 during trading on Friday, hitting $86.58. The company's stock had a trading volume of 4,075,712 shares, compared to its average volume of 2,984,066. The firm's 50 day moving average price is $86.77 and its two-hundred day moving average price is $86.15. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80. The stock has a market capitalization of $39.59 billion, a price-to-earnings ratio of 20.00, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13.

Remove Ads

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Analyst Ratings Changes

GEHC has been the topic of a number of research analyst reports. Citigroup raised their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a report on Thursday, February 13th. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. One research analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.